Jenburkt Pharmaceuticals Ltd
BSE:524731

Watchlist Manager
Jenburkt Pharmaceuticals Ltd Logo
Jenburkt Pharmaceuticals Ltd
BSE:524731
Watchlist
Price: 1 242.4 INR -3.73% Market Closed
Market Cap: 5.5B INR
Have any thoughts about
Jenburkt Pharmaceuticals Ltd?
Write Note

Intrinsic Value

The intrinsic value of one JENBURPH stock under the Base Case scenario is 781.67 INR. Compared to the current market price of 1 242.4 INR, Jenburkt Pharmaceuticals Ltd is Overvalued by 37%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

JENBURPH Intrinsic Value
781.67 INR
Overvaluation 37%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Jenburkt Pharmaceuticals Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
JENBURPH
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for JENBURPH cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about JENBURPH?
Bearish
Neutral
Bullish

Fundamental Analysis

1 242.4 INR
-3.73%
-3.73%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Jenburkt Pharmaceuticals Ltd
IN
Pharmaceuticals
Market Cap
5.5B INR
IPO
Oct 18, 1994
Employees
730
India
Market Cap
5.5B INR
Industry
Pharmaceuticals
IPO
Oct 18, 1994
Company Overview
Loading...
Economic Moat
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Jenburkt Pharmaceuticals Ltd

Provide an overview of the primary business activities
of Jenburkt Pharmaceuticals Ltd.

What unique competitive advantages
does Jenburkt Pharmaceuticals Ltd hold over its rivals?

What risks and challenges
does Jenburkt Pharmaceuticals Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Jenburkt Pharmaceuticals Ltd.

Provide P/S
for Jenburkt Pharmaceuticals Ltd.

Provide P/E
for Jenburkt Pharmaceuticals Ltd.

Provide P/OCF
for Jenburkt Pharmaceuticals Ltd.

Provide P/FCFE
for Jenburkt Pharmaceuticals Ltd.

Provide P/B
for Jenburkt Pharmaceuticals Ltd.

Provide EV/S
for Jenburkt Pharmaceuticals Ltd.

Provide EV/GP
for Jenburkt Pharmaceuticals Ltd.

Provide EV/EBITDA
for Jenburkt Pharmaceuticals Ltd.

Provide EV/EBIT
for Jenburkt Pharmaceuticals Ltd.

Provide EV/OCF
for Jenburkt Pharmaceuticals Ltd.

Provide EV/FCFF
for Jenburkt Pharmaceuticals Ltd.

Provide EV/IC
for Jenburkt Pharmaceuticals Ltd.

Show me price targets
for Jenburkt Pharmaceuticals Ltd made by professional analysts.

What are the Revenue projections
for Jenburkt Pharmaceuticals Ltd?

How accurate were the past Revenue estimates
for Jenburkt Pharmaceuticals Ltd?

What are the Net Income projections
for Jenburkt Pharmaceuticals Ltd?

How accurate were the past Net Income estimates
for Jenburkt Pharmaceuticals Ltd?

What are the EPS projections
for Jenburkt Pharmaceuticals Ltd?

How accurate were the past EPS estimates
for Jenburkt Pharmaceuticals Ltd?

What are the EBIT projections
for Jenburkt Pharmaceuticals Ltd?

How accurate were the past EBIT estimates
for Jenburkt Pharmaceuticals Ltd?

Compare the revenue forecasts
for Jenburkt Pharmaceuticals Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Jenburkt Pharmaceuticals Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Jenburkt Pharmaceuticals Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Jenburkt Pharmaceuticals Ltd compared to its peers.

Compare the P/E ratios
of Jenburkt Pharmaceuticals Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Jenburkt Pharmaceuticals Ltd with its peers.

Analyze the financial leverage
of Jenburkt Pharmaceuticals Ltd compared to its main competitors.

Show all profitability ratios
for Jenburkt Pharmaceuticals Ltd.

Provide ROE
for Jenburkt Pharmaceuticals Ltd.

Provide ROA
for Jenburkt Pharmaceuticals Ltd.

Provide ROIC
for Jenburkt Pharmaceuticals Ltd.

Provide ROCE
for Jenburkt Pharmaceuticals Ltd.

Provide Gross Margin
for Jenburkt Pharmaceuticals Ltd.

Provide Operating Margin
for Jenburkt Pharmaceuticals Ltd.

Provide Net Margin
for Jenburkt Pharmaceuticals Ltd.

Provide FCF Margin
for Jenburkt Pharmaceuticals Ltd.

Show all solvency ratios
for Jenburkt Pharmaceuticals Ltd.

Provide D/E Ratio
for Jenburkt Pharmaceuticals Ltd.

Provide D/A Ratio
for Jenburkt Pharmaceuticals Ltd.

Provide Interest Coverage Ratio
for Jenburkt Pharmaceuticals Ltd.

Provide Altman Z-Score Ratio
for Jenburkt Pharmaceuticals Ltd.

Provide Quick Ratio
for Jenburkt Pharmaceuticals Ltd.

Provide Current Ratio
for Jenburkt Pharmaceuticals Ltd.

Provide Cash Ratio
for Jenburkt Pharmaceuticals Ltd.

What is the historical Revenue growth
over the last 5 years for Jenburkt Pharmaceuticals Ltd?

What is the historical Net Income growth
over the last 5 years for Jenburkt Pharmaceuticals Ltd?

What is the current Free Cash Flow
of Jenburkt Pharmaceuticals Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Jenburkt Pharmaceuticals Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Jenburkt Pharmaceuticals Ltd

Current Assets 1B
Cash & Short-Term Investments 780.9m
Receivables 153.7m
Other Current Assets 107.4m
Non-Current Assets 772.8m
Long-Term Investments 319.6m
PP&E 146.8m
Intangibles 2.9m
Other Non-Current Assets 303.5m
Current Liabilities 177m
Accounts Payable 57.2m
Accrued Liabilities 13.6m
Short-Term Debt 4.1m
Other Current Liabilities 102.2m
Non-Current Liabilities 60.1m
Long-Term Debt 17.1m
Other Non-Current Liabilities 43m
Efficiency

Earnings Waterfall
Jenburkt Pharmaceuticals Ltd

Revenue
1.5B INR
Cost of Revenue
-302.3m INR
Gross Profit
1.2B INR
Operating Expenses
-826.7m INR
Operating Income
353.6m INR
Other Expenses
-50.5m INR
Net Income
303m INR

Free Cash Flow Analysis
Jenburkt Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

JENBURPH Profitability Score
Profitability Due Diligence

Jenburkt Pharmaceuticals Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Year Average ROIC
Positive 3-Year Average ROE
Exceptional ROIC
64/100
Profitability
Score

Jenburkt Pharmaceuticals Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

JENBURPH Solvency Score
Solvency Due Diligence

Jenburkt Pharmaceuticals Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
75/100
Solvency
Score

Jenburkt Pharmaceuticals Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

JENBURPH Price Targets Summary
Jenburkt Pharmaceuticals Ltd

There are no price targets for JENBURPH.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for JENBURPH?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for JENBURPH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one JENBURPH stock?

The intrinsic value of one JENBURPH stock under the Base Case scenario is 781.67 INR.

Is JENBURPH stock undervalued or overvalued?

Compared to the current market price of 1 242.4 INR, Jenburkt Pharmaceuticals Ltd is Overvalued by 37%.

Back to Top